KIR ligands carried by the NK-cell donor (P61) or by different mDCs and T-cell targets
. | HLA class I epitope . | |||||
---|---|---|---|---|---|---|
C1* . | C2* . | HLA-Bw4 T80† . | HLA-Bw4 I80† . | HLA-Bw6† . | HLA-A Bw4+* . | |
P61 | P | A | P | A | A | P |
GF | A | P | P | A | P | A |
SC | P | P | A | P | A | P |
RB | A | P | A | P | A | A |
CV | P | P | A | P | A | A |
. | HLA class I epitope . | |||||
---|---|---|---|---|---|---|
C1* . | C2* . | HLA-Bw4 T80† . | HLA-Bw4 I80† . | HLA-Bw6† . | HLA-A Bw4+* . | |
P61 | P | A | P | A | A | P |
GF | A | P | P | A | P | A |
SC | P | P | A | P | A | P |
RB | A | P | A | P | A | A |
CV | P | P | A | P | A | A |
DNA of the indicated samples have been tested by sequence-specific polymorphism PCR (SSP-PCR) approach to define KIR ligands. Results obtained using set of primers that allowed to detect the presence (P) or the absence (A) of HLA-C alleles coding for C1 (HLA-C N80) or C2 (HLA-C K80) epitope, of HLA-Bw4 alleles carrying a threonine (T) or a isoleucine (I) at position 80, and of HLA-A alleles characterized by the Bw4 public epitope.
RNA of the indicated samples have been tested by SSP-PCR approach to define KIR ligands. Results obtained using set of primers that selectively amplify HLA-B alleles sharing Bw6 epitope.